Immunoreactive serum trypsin in diseases of the pancreas

Klin Wochenschr. 1979 Nov 15;57(22):1237-8. doi: 10.1007/BF01489252.

Abstract

Immunoreactive serum trypsin was measured with a double antibody radioimmunoassay in normal subjects and patients with various diseases of the pancreas. The normal range is 115-350 ng/ml with a geometric mean of 212 ng/ml. No trypsin was found in serum after total duodenopancreatectomy, in about 75% of patients with cystic fibrosis and in a few patients with pancreas carcinoma or chronic pancreatitis. Reduced serum trypsin levels between 10 and 100 ng/ml were measured in the remaining 25% of cystic fibrosis and in one third of the patients with chronic pancreatitis. Serum trypsin was increased to 700-17,000 ng/ml in all patients with acute pancreatitis or during the acute phase of chronic pancreatitis. Absent or reduced serum trypsin is a reliable indicator of total or partial exocrine pancreatic insufficiency whereas considerably increased serum trypsin concentration do indicate acute pancreatitis.

MeSH terms

  • Acute Disease
  • Chronic Disease
  • Cystic Fibrosis / enzymology
  • Humans
  • Pancreatectomy
  • Pancreatic Diseases / enzymology*
  • Pancreatitis / enzymology
  • Radioimmunoassay
  • Trypsin / blood*

Substances

  • Trypsin